Christine Ryan: Clinical Trials

3 trials sponsored by Christine Ryan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Active not recruiting 1

Follow Christine Ryan: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
Bendamustine, Rituximab, Cytarabine - Mantle Cell Lymphoma, Lymphoma
Phase 2RecruitingChristine Ryan602025-04-222026-02-20
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Glofitamab, Obinutuzumab, Polatuzumab Vedotin - Chronic Lymphocytic Leukemia, Richter's Transformation
Phase 2RecruitingChristine Ryan702024-01-222026-10-21
Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
Rituximab, Bendamustine, Cytarabine - Mantle Cell Lymphoma
Phase 2Active not recruitingChristine Ryan232012-08-162026-06-08

Conditions studied

Lymphoma, Mantle-Cell (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma (1)

Interventions

Bendamustine Hydrochloride (2)  ·  Cytarabine (2)  ·  Rituximab (2)  ·  atezolizumab (1)  ·  glofitamab (1)  ·  obinutuzumab (1)  ·  pirtobrutinib (1)  ·  polatuzumab vedotin (1)  ·  tocilizumab (1)  ·  zanubrutinib (1)

Countries

United States (3)

Results publications

PMID 26729345, PMID 32126141